Lyophilized preparation of anti-human Her2 antibody
A technology of freeze-dried preparations and antibodies, applied in the field of anti-Her2 monoclonal antibody freeze-dried preparations, can solve the problems of loss of activity, prone to physical and chemical reactions, easy aggregation, etc., achieve good safety and tolerance, and facilitate large-scale production , high protein stability
Inactive Publication Date: 2010-06-09
HARBIN PHARMA GROUP BIOLOGICAL ENG
View PDF3 Cites 9 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0007] James D. Andia; Wei Junxiang; Liu Jun; Shen Ye invented the liquid preparation of anti-Her2 antibody protein (patent name: antibody preparation in histidine-acetate buffer, Patent No.: 200580043463.5) Its shortcoming is that the protein in the form of liquid preparation is more prone to physical and chemical reactions, such as deamidation reaction, oxidation or hydrolysis by other substances, and secondly, when the concentration of protein in aqueous solution is too high Easy to aggregate, easy to produce immune response after injection into the human body
More importantly, during the long-distance transportation of liquid preparations, severe shocks will easily denature proteins and lose their activity
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 2
[0019] Example 2: Solution A
[0020] Element
Embodiment 3
[0021] Example 3: Solution B
[0022] Element
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention provides a preparation method of a lyophilized preparation of an anti-human Her2 antibody. The lyophilized preparation of the anti-Her2 antibody is prepared from the anti-Her2 antibody, a protective agent, excipient and buffer salts through lyophilization. The lyophilized preparation of the anti-Her2 antibody has the advantages of good stability, prolonged valid period, and easy storage and transportation.
Description
technical field [0001] The invention belongs to the field of biotechnology and relates to a stable anti-Her2 monoclonal antibody freeze-dried preparation. Background technique [0002] Her2 receptor is one of the four members of the human epidermal growth factor receptor family, and is expressed in various tumors such as breast cancer, ovarian cancer, gastric cancer, bladder cancer, and non-small cell lung cancer. Overexpression of Her2 will increase the ability of tumor cells to invade and metastasize. Therefore, the level of Her2 expression is closely related to the clinical diagnosis, drug efficacy and prognosis of breast cancer and ovarian cancer. specific target. [0003] Humanized anti-HER2 antibodies are produced by mammalian cells (Chinese hamster ovary cells CHO) suspended in sterile medium and purified by affinity chromatography and ion exchange, including removal of specific virus inactivation program. Anti-Her2 antibody is a humanized monoclonal antibody deriv...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
IPC IPC(8): A61K39/395A61K47/10A61K47/16A61K47/26A61K47/34A61K9/19A61P35/00
Inventor 李郑武刘高波李会成陈玉军冷国庆赵华南高晶
Owner HARBIN PHARMA GROUP BIOLOGICAL ENG
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com